For a specific exposure-outcome combination of interest to you, specify which lifecourse model is likely most appropriate and why you think this is the case. Describe the regression models you could use to test your hypothesis. Are there any possible data sets in which this test could be conducted, and if so, what concerns would you have about interpreting your proposed test of the lifecourse model?
Exposure: infection with TB
For previously uninfected individuals this would correspond to the change from TST negative to TST positive. For previously infected individuals, additional infections can occur but are unobserved.
Outcome: clinical disease (about 90% of those infected do not develop clinical disease)
Lifecourse model: Accumulation of risk + sensitive period
We know that individuals with household contact who are infected are far more likely to develop clinical disease than those who are infected from casual contact. This lends support to an accumulation of risk model. However, there is also reason to believe that there is a sensitive period of about 18 months after an infection during which additional infections confer additional risk beyond the risk conferred by additional infections after 18 months.
Regression models:
Well, this is tricky since reinfection is unobserved. Furthermore, it's unclear how multiple infections might cause disease within this 18 month sensitive period. Perhaps, 2 infections in an 18 month window is worse than 1, and 3 is worse than 2. But perhaps at some point there has been so much repeated exposure that say 5 infections isn't worse than 4, for example.
Also, it's unclear whether multiple infections within an 18 month period increases your lifetime risk or just your risk within about a 1-5 year period following the 18 month period. The latter is more likely to be true, but I will assume the former.
I will also make the following simplifying assumptions as a first stab at the problem:
- Each infection increases the hazard developing active disease
- Each additional infection within an 18 month period increases the hazard of active disease
Proportional Hazard model:
\lambda (t|x) = \lambda_0 (t) exp(beta_1 N + beta_2 \sum_i M_i (L_i - 1) + beta_3 X N )
Where t is the time since most recent infection, \lambda (t|x) is the hazard of disease, N is lifetime number of infections, M_i is the number of 18 month periods during which multiple infections occurred, and L_i is the number of infections accumulated during that period. Here, I would define \lambda_0 (t) to be the hazard for an individual with 1 infection, since infection is a necessary cause of disease.
Notes:
There is no intercept in this model, since you must be infected to get active TB!
Also, I didn't get into what the covariates X are, but you could imagine interaction terms between sex and number of infections--e.g. women who are infected have lower risk of active disease than men who are infected.
Datasets and interpretation
There are many datasets with TST status and active disease. The difficult things about this problem are
1) Multiple infections are unobserved. We could, however, make assumptions about infections given known exposure to active cases.
2) TB is dynamical.
So, I think ultimately a dynamical model would be more productive here--a model that includes partially observed states (i.e. infection) and instead fits an observed outcome like progression to disease using a model with constant risk of infection versus accumulation + sensitive period.